{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:04:56Z","timestamp":1761512696226},"reference-count":122,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/ogx.0b013e3181a713f1","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T07:27:07Z","timestamp":1245742027000},"page":"469-480","source":"Crossref","is-referenced-by-count":6,"title":["Women's Health, Breast Health"],"prefix":"10.1097","volume":"64","author":[{"given":"Mindy","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"O'Hair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-21-20210212","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends and multiple primary cancer analysis from the Surveillance, Epidemiology and End Results (SEER) program.","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"R3-21-20210212","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1200\/JCO.2004.01.159","article-title":"Web-Based survey of fertility issues in young women with breast cancer.","volume":"22","author":"Partridge","year":"2004","journal-title":"J Clin Oncol"},{"key":"R4-21-20210212","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/annonc\/mdh266","article-title":"Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.","volume":"15","author":"Di Cosimo","year":"2004","journal-title":"Ann Oncol"},{"key":"R5-21-20210212","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3816\/CBC.2005.n.046","article-title":"Chemotherapy-induced amenorrheafrom adjuvant breast cancer treatment: the effect of the addition of taxanes.","volume":"6","author":"Davis","year":"2005","journal-title":"Clin Breast Cancer"},{"key":"R6-21-20210212","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJM200106283442607","article-title":"Side effects of adjuvant treatment of breast cancer.","volume":"344","author":"Shapiro","year":"2001","journal-title":"N Engl J Med"},{"key":"R7-21-20210212","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1089\/jwh.1.1999.8.949","article-title":"The risk of premature menopause induced by chemotherapy for early breast cancer.","volume":"8","author":"Lower","year":"1999","journal-title":"J Women's Health Gend Based Med"},{"key":"R8-21-20210212","first-page":"50s","article-title":"Delayed premature menopause following chemotherapy for early stage breast cancer: long term results from IBSCG Trial V.","volume":"16s","author":"Partridge","year":"2005","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R9-21-20210212","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ejogrb.2003.11.004","article-title":"Oocyte cryopreservation in oncological patients.","volume":"113","author":"Porcu","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R10-21-20210212","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMc055237","article-title":"Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy.","volume":"353","author":"Meirow","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-21-20210212","first-page":"259","article-title":"In vitro fertilization and breast cancer risk: a review.","volume":"50","author":"Salhab","year":"2005","journal-title":"Int J Fertil Womens Med"},{"key":"R12-21-20210212","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1471-0528.1973.tb11230.x","article-title":"The induction of ovulation by tamoxifen.","volume":"80","author":"Williamson","year":"1973","journal-title":"J Obstet Gynaecol Br Commonw"},{"key":"R13-21-20210212","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/humrep\/deg311","article-title":"Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility.","volume":"18","author":"Mitwally","year":"2003","journal-title":"Hum Reprod"},{"key":"R14-21-20210212","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study.","volume":"26","author":"Azim","year":"2008","journal-title":"J Clin Oncol"},{"key":"R15-21-20210212","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1095\/biolreprod52.2.365","article-title":"Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys.","volume":"52","author":"Ataya","year":"1995","journal-title":"Biol Reprod"},{"key":"R16-21-20210212","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/oxfordjournals.humrep.a019457","article-title":"Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.","volume":"11","author":"Blumenfeld","year":"1996","journal-title":"Hum Reprod"},{"key":"R17-21-20210212","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","article-title":"How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embryos, oocytes, or ovaries.","volume":"12","author":"Blumenfeld","year":"2007","journal-title":"Oncologist"},{"key":"R18-21-20210212","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJMc052108","article-title":"Options for preservation of fertility in women.","volume":"353","author":"Goodwin","year":"2005","journal-title":"N Engl J Med"},{"key":"R19-21-20210212","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1200\/JCO.1999.17.3.855","article-title":"Management of breast cancer during pregnancy using a standardized protocol.","volume":"17","author":"Berry","year":"1999","journal-title":"J Clin Oncol"},{"key":"R20-21-20210212","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1349-7006.1992.tb02737.x","article-title":"Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case\u2013control study in Japan.","volume":"83","author":"Ishida","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"R21-21-20210212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1742-1241.2002.tb11230.x","article-title":"Breast cancer in young women [review].","volume":"56","author":"Kothari","year":"2002","journal-title":"Int J Clin Pract"},{"key":"R22-21-20210212","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","article-title":"Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.","volume":"107","author":"Hahn","year":"2006","journal-title":"Cancer"},{"key":"R23-21-20210212","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/annonc\/mdi388","article-title":"Breast cancer in pregnancy.","volume":"16","author":"Ring","year":"2005","journal-title":"Ann Oncol"},{"key":"R24-21-20210212","article-title":"Diagnostic Medical Exposures: Advice on Exposure to Ionizing Radiation During Pregnancy.","author":"Sharp","year":"1998"},{"key":"R25-21-20210212","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/cncr.11634","article-title":"Childbearing and survival after breast carcinoma in young women.","volume":"98","author":"Mueller","year":"2003","journal-title":"Cancer"},{"key":"R26-21-20210212","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomized trials.","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"R27-21-20210212","first-page":"2747","article-title":"A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer [Erratum in: N Engl J Med 2006;354:2200].","volume":"353","author":"Th\u00fcrlimann","year":"2005","journal-title":"N Engl J Med"},{"key":"R28-21-20210212","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(04)17666-6","article-title":"(Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.","volume":"365","author":"Howell","year":"2005","journal-title":"Lancet"},{"key":"R29-21-20210212","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/jnci\/dji250","article-title":"Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA 17.","volume":"97","author":"Goss","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R30-21-20210212","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Intergroup Exemestane Study. Survival and safety of exemestane versus tamoxifen after 2\u20133 years' tamoxifen treatment (Intergroup Exemestane Study): a randomized controlled trial.","volume":"17","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"R31-21-20210212","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"key":"R32-21-20210212","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1200\/JCO.2005.04.120","article-title":"Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.","volume":"23","author":"Boccardo","year":"2005","journal-title":"J Clin Oncol"},{"key":"R33-21-20210212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/gyno.1998.5201","article-title":"Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.","volume":"72","author":"Cohen","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R34-21-20210212","first-page":"855","article-title":"Tamoxifen treatment and gynecologic side effects: a review.","volume":"97","author":"Mourits","year":"2001","journal-title":"Obstet Gynecol"},{"key":"R35-21-20210212","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1200\/JCO.1991.9.7.1283","article-title":"Tamoxifen in premenopausal patients with metastatic breast cancer. A review.","volume":"9","author":"Sunderland","year":"1991","journal-title":"J Clin Oncol"},{"key":"R36-21-20210212","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1038\/sj.bjc.6690280","article-title":"Ovarian cysts in women receiving tamoxifen for breast cancer.","volume":"79","author":"Mourits","year":"1999","journal-title":"Br J Cancer"},{"key":"R37-21-20210212","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ajog.2004.12.083","article-title":"Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.","volume":"192","author":"Chalas","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R38-21-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(86)90087-9","article-title":"Occurrence of genital tract abnormalities and bladder hernia in female mice exposed neonatally to tamoxifen.","volume":"42","author":"Iguchi","year":"1986","journal-title":"Toxicology"},{"key":"R39-21-20210212","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/carcin\/18.10.2009","article-title":"Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen.","volume":"18","author":"Diwan","year":"1997","journal-title":"Carcinogenesis"},{"key":"R40-21-20210212","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.breast.2004.08.007","article-title":"Tamoxifen and pregnancy.","volume":"13","author":"Barthelmes","year":"2004","journal-title":"Breast"},{"key":"R41-21-20210212","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO.1999.17.5.1488","article-title":"Effect of tamoxifen on sexual functioning in patients with breast cancer.","volume":"17","author":"Mortimer","year":"1999","journal-title":"J Clin Oncol"},{"key":"R42-21-20210212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01806673","article-title":"Breast cancer survivors: psychosocial concerns and quality of life.","volume":"38","author":"Ganz","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"R43-21-20210212","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/S0140-6736(94)92466-X","article-title":"Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial.","volume":"343","author":"Kedar","year":"1994","journal-title":"Lancet"},{"key":"R44-21-20210212","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1994.116","article-title":"Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formation and fibroid overgrowth.","volume":"63","author":"Cohen","year":"1994","journal-title":"Br J Cancer"},{"key":"R45-21-20210212","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0028-2243(94)90258-5","article-title":"Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the antioestrogen tamoxifen.","volume":"54","author":"Ugwumadu","year":"1994","journal-title":"Eur J Obstet Gynecol"},{"key":"R46-21-20210212","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0002-9378(88)90233-5","article-title":"Endometriosis developing during tamoxifen therapy.","volume":"158","author":"Ford","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"R47-21-20210212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/gyno.1995.1188","article-title":"Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity?","volume":"58","author":"Cohen","year":"1995","journal-title":"Gynecol Oncol"},{"key":"R48-21-20210212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/gyno.1997.4739","article-title":"Comparison of endometrial changes among symptomatic tamoxifen treated and nontreated premenopausal and postmenopausal breast cancer patients.","volume":"66","author":"Cheng","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R49-21-20210212","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast-cancer prevention trials.","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"R50-21-20210212","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen.","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"R51-21-20210212","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s004040050276","article-title":"The endometrium in breast cancer patients on tamoxifen.","volume":"263","author":"Dallenbach-Hellweg","year":"2000","journal-title":"Arch Gynecol Obstet"},{"key":"R52-21-20210212","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/ejso.1999.0682","article-title":"Tamoxifen and malignant epithelial\u2013nonepithelial tumours of the endometrium: report of six cases and review of the literature.","volume":"25","author":"Treilleux","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"R53-21-20210212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.22734","article-title":"Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer: comparison of cohorts treated with and without tamoxifen.","volume":"110","author":"Saadat","year":"2007","journal-title":"Cancer"},{"key":"R54-21-20210212","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ygyno.2005.10.026","article-title":"Comparison of uterine malignancies that develop during and following tamoxifen therapy.","volume":"101","author":"Ferguson","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R55-21-20210212","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","article-title":"Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.","volume":"18","author":"Gerber","year":"2000","journal-title":"J Clin Oncol"},{"key":"R56-21-20210212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10549-006-9193-0","article-title":"Adherence to tamoxifen over the five-year course.","volume":"99","author":"Lash","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"R57-21-20210212","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(05)67059-6","article-title":"Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.","volume":"366","author":"Jakesz","year":"2005","journal-title":"Lancet"},{"key":"R58-21-20210212","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/humrep\/dei322","article-title":"The ATAC (\u2018Arimidex,\u2019 Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.","volume":"21","author":"Duffy","year":"2006","journal-title":"Hum Reprod"},{"key":"R59-21-20210212","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa040331","article-title":"A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.","volume":"350","author":"Coombes","year":"2004","journal-title":"N Engl J Med"},{"key":"R60-21-20210212","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.","volume":"349","author":"Goss","year":"2003","journal-title":"N Engl J Med"},{"key":"R61-21-20210212","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/cncr.11745","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.","volume":"98","author":"Baum","year":"2003","journal-title":"Cancer"},{"key":"R62-21-20210212","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/CCO.0b013e3281a7ef3a","article-title":"Hormonal therapy of endometrial stromal sarcoma.","volume":"19","author":"Reich","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R63-21-20210212","first-page":"736","article-title":"Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture.","volume":"78","author":"Bulun","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R64-21-20210212","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.fertnstert.2003.09.029","article-title":"Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.","volume":"81","author":"Ailawadi","year":"2004","journal-title":"Fertil Steril"},{"key":"R65-21-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/s-2004-823027","article-title":"Aromatase and Leomyoma of the Uterus","volume":"22","author":"Shozu","year":"2004","journal-title":"Semin Reprod Med"},{"key":"R66-21-20210212","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.ogx.0000238649.97517.22","article-title":"Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifen for breast cancer prevention. The NSABP study of tamoxifen and raloxifen (STAR) P-2 Trial.","volume":"61","author":"Land","year":"2006","journal-title":"Obstet Gynecol Surv"},{"key":"R67-21-20210212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/14737140.9.1.51","article-title":"The NSABP Study of Tamoxifen and Raloxifene (STAR) trial.","volume":"9","author":"Vogel","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"R68-21-20210212","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/13697130500487224","article-title":"Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.","volume":"9","author":"Gupta","year":"2006","journal-title":"Climacteric"},{"key":"R69-21-20210212","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R70-21-20210212","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00003081-200406000-00023","article-title":"Menopausal changes, quality of life, and hormonetherapy.","volume":"47","author":"Nachtigall","year":"2004","journal-title":"Clin Obstet Gynecol"},{"key":"R71-21-20210212","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS Steering and Data Monitoring Committees. HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomized camparison: trial stopped.","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"R72-21-20210212","first-page":"230","article-title":"Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.","volume":"29","author":"Bordeleau","year":"2007","journal-title":""},{"key":"R73-21-20210212","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.amjmed.2005.09.044","article-title":"Menopause: a review of botanical dietary supplements.","volume":"118","author":"Low Dog","year":"2005","journal-title":"Am J Med"},{"key":"R74-21-20210212","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phrs.2008.05.008","article-title":"Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy.","volume":"58","author":"Borrelli","year":"2008","journal-title":"Pharmacol Res"},{"key":"R75-21-20210212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.AOG.0000147840.06947.46","article-title":"Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.","volume":"105","author":"Evans","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R76-21-20210212","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/S0140-6736(07)60959-3","article-title":"Clinical update: new treatments for hot flushes.","volume":"369","author":"Stearns","year":"2007","journal-title":"Lancet"},{"key":"R77-21-20210212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000297371.89129.b3","article-title":"Study 315 Investigators. Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.","volume":"111","author":"Speroff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R78-21-20210212","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","article-title":"Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients-a double-blind, randomized study.","volume":"18","author":"Loibl","year":"2007","journal-title":"Ann Oncol"},{"key":"R79-21-20210212","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.4065\/77.11.1159","article-title":"Pilot evaluation of gabapentin for treating hot flashes.","volume":"77","author":"Loprinzi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R80-21-20210212","first-page":"337","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R81-21-20210212","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomized double-blind placebo-controlled trial.","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"key":"R82-21-20210212","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1592\/phco.29.1.74","article-title":"Use of gabapentin in patients experiencing hot flashes.","volume":"29","author":"Brown","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R83-21-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1471-0528.2004.00309.x","article-title":"The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.","volume":"112","author":"Kroiss","year":"2005","journal-title":"BJOG"},{"key":"R84-21-20210212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women: systematicreview of randomized trials.","volume":"87","author":"Modelska","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R85-21-20210212","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.maturitas.2004.06.019","article-title":"Self-reported urogential symptoms in postmenopausal women: women's health initiative.","volume":"49","author":"Pastore","year":"2004","journal-title":"Maturitas"},{"key":"R86-21-20210212","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.GME.0000075502.60230.28","article-title":"The impact of hormones on menopausal sexuality: a literature review.","volume":"11","author":"Bachman","year":"2004","journal-title":"Menopause"},{"key":"R87-21-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","article-title":"Replens versus dienostrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.","volume":"23","author":"Bygdeman","year":"1996","journal-title":"Maturitas"},{"key":"R88-21-20210212","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1200\/JCO.1997.15.3.969","article-title":"Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.","volume":"15","author":"Loprinzi","year":"1997","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"R89-21-20210212","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-5122(95)00961-2","article-title":"New kinetic data on estradiol in light of the vaginal ring concept.","volume":"22","author":"Gabrielsson","year":"1995","journal-title":"Maturitas"},{"key":"R90-21-20210212","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R91-21-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer.","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric"},{"key":"R92-21-20210212","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/annonc\/mdn353","article-title":"Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer.","volume":"19","author":"Hickey","year":"2008","journal-title":"Ann Oncol"},{"key":"R93-21-20210212","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/j.1471-0528.2002.02020.x","article-title":"Dose-response analysis of effects of tibolone on climacteric symptoms.","volume":"109","author":"Landgren","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"R94-21-20210212","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"R95-21-20210212","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R96-21-20210212","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-0528.1998.tb10237.x","article-title":"A double-blind randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.","volume":"105","author":"Hammar","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R97-21-20210212","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-0528.1999.tb08436.x","article-title":"Long-term effects of tibolone on the genital tract in postmenopausal women.","volume":"106","author":"Morris","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"R98-21-20210212","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.gme.0000247016.41007.c9","article-title":"Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.","volume":"13","author":"Swanson","year":"2006","journal-title":"Menopause"},{"key":"R99-21-20210212","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-caner patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.","volume":"10","author":"Kenemans","year":"2009","journal-title":"The Lancet Oncology"},{"key":"R101-21-20210212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.smrv.2003.10.001","article-title":"Impaired sleep and rhythms in persons with cancer.","volume":"8","author":"Lee","year":"2004","journal-title":"Sleep Med Rev"},{"key":"R102-21-20210212","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.soncn.2007.08.007","article-title":"Exercise and quality of life outcomes in patients with cancer.","volume":"23","author":"Knobf","year":"2007","journal-title":"Seminin Oncol Nurs"},{"issue":"suppl 4","key":"R103-21-20210212","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0015-0282(02)03001-7","article-title":"Hormones, mood, sexuality, and the menopausal transition.","volume":"77","author":"Dennerstein","year":"2002","journal-title":"Fertil Steril"},{"key":"R104-21-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00042192-200103000-00006","article-title":"Factors related to sexual function in postmenopausal women with a history of breast cancer.","volume":"8","author":"Greendale","year":"2001","journal-title":"Menopause"},{"key":"R105-21-20210212","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/jnci\/92.17.1422","article-title":"Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors [Erratum in: J Natl Cancer Inst 2001;93:68].","volume":"92","author":"Rowland","year":"2000","journal-title":"J Natl Cancer Ins"},{"key":"R106-21-20210212","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/cmt.4.1.28.41","article-title":"The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.","volume":"4","author":"Laan","year":"2001","journal-title":"Climacteric"},{"key":"R107-21-20210212","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.jcp.0000125686.20338.c1","article-title":"Buproprion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women.","volume":"3","author":"Segraves","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R109-21-20210212","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1743-6109.2007.00577.x","article-title":"A case series of androgen use in breast cancer survivors with sexual dysfunction.","volume":"4","author":"Krychman","year":"2007","journal-title":"J Sex Med"},{"key":"R110-21-20210212","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ecl.2004.07.001","article-title":"Bone health and aging: implications for menopause.","volume":"33","author":"Mirza","year":"2004","journal-title":"Endocrinol Metab Clin N Am"},{"key":"R111-21-20210212","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archinte.165.5.552","article-title":"Fracture risk among breast cancer survivors: results from the Women's Health initiative Observational Study.","volume":"165","author":"Chen","year":"2005","journal-title":"Arch Intern Med"},{"key":"R112-21-20210212","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer.","volume":"19","author":"Shapiro","year":"2001","journal-title":"J Clinical Oncol"},{"key":"R113-21-20210212","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","article-title":"Osteoporosis due to cancer treatment: pathogenesis and management.","volume":"18","author":"Pfeilschifter","year":"2000","journal-title":"J Clini Oncol"},{"key":"R114-21-20210212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2006.05.011","article-title":"How long should patients take medications for postmenopausal osteoporosis?","volume":"74","author":"Briot","year":"2007","journal-title":"Joint Bone Spine"},{"issue":"suppl 20","key":"R115-21-20210212","doi-asserted-by":"crossref","first-page":"6309s","DOI":"10.1158\/1078-0432.CCR-06-0652","article-title":"Skeletal complications of breast cancer therapies.","volume":"12","author":"Hirbe","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R116-21-20210212","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.seminoncol.2003.08.028","article-title":"Osteopenia and osteoporosis in women with breast cancer.","volume":"30","author":"Ramaswamy","year":"2003","journal-title":"Seminin Oncol"},{"key":"R117-21-20210212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10549-004-2625-9","article-title":"Baseline bone mineral density of the total lumbar spine may predict for chemotherapy-induced ovarian failure.","volume":"90","author":"Shapiro","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R118-21-20210212","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ejca.2005.10.028","article-title":"Effects of third-generation aromatase inhibitors on bone.","volume":"42","author":"McCloskey","year":"2006","journal-title":"Eur J Cancer"},{"key":"R119-21-20210212","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/bcr448","article-title":"Familial risks of breast cancer.","volume":"4","author":"Easton","year":"2002","journal-title":"Breast Cancer Res"},{"key":"R120-21-20210212","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1056\/NEJM199705153362001","article-title":"The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.","volume":"336","author":"Struewing","year":"1997","journal-title":"N Engl J Med"},{"key":"R121-21-20210212","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R122-21-20210212","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.","volume":"15","author":"Warner","year":"2004","journal-title":"JAMA"},{"key":"R123-21-20210212","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.2004.04.188","article-title":"Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.","volume":"22","author":"Rebbeck","year":"2004","journal-title":"J Clin Oncol"},{"key":"R124-21-20210212","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/jnci\/91.17.1475","article-title":"Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.","volume":"91","author":"Rebbeck","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R125-21-20210212","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Obstetrical & Gynecological Survey"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006254-200907000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T20:25:05Z","timestamp":1710447905000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006254-200907000-00021"}},"subtitle":["A Review of the Gynecologic Effects of Breast Cancer"],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":122,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ogx.0b013e3181a713f1","relation":{},"ISSN":["0029-7828"],"issn-type":[{"value":"0029-7828","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}